Medicine & Life Sciences
Precision Medicine
100%
Breast Neoplasms
59%
ertumaxomab
34%
In Situ Hybridization
28%
pertuzumab
24%
Lapatinib
21%
erbB-2 Genes
21%
Somatomedin Receptors
20%
Biomarkers
20%
Taxoids
20%
Tensins
20%
Chromosomes, Human, Pair 17
19%
Everolimus
19%
Circulating Neoplastic Cells
19%
human ERBB2 protein
18%
Trastuzumab
18%
Medical Oncology
18%
Gene Amplification
18%
Anthracyclines
17%
Dimerization
17%
Bevacizumab
17%
Receptor Protein-Tyrosine Kinases
16%
Oligonucleotide Array Sequence Analysis
16%
Phosphoric Monoester Hydrolases
15%
Fluorescence In Situ Hybridization
15%
Therapeutics
15%
Pathologists
15%
Oncogenes
14%
Protein-Tyrosine Kinases
14%
Chromosomes
12%
Real-Time Polymerase Chain Reaction
12%
Phosphotransferases
11%
Vaccines
11%
Immunohistochemistry
10%
Guidelines
9%
Messenger RNA
8%
Survival
8%
Proteins
5%